Related Experiment Video
Updated: Apr 22, 2026
08:27
Real-time Cytotoxicity Assays in Human Whole Blood
Published on: November 7, 2014
11.8K
Immunotoxicology and the new biotechnology
1Joy Cavagnaro is a Senior Staff Scientist at Hazleton Laboratories America, Vienna, VA 22075, USA.
Immunology Today
|October 8, 2014
Summary
Pharmaceutical products, including immune modulators and others, require immunotoxicology assessment. Preclinical safety evaluations must define the potential adverse effects of these novel bioprocessed therapeutics on the immune system.
Area of Science:
- Pharmaceutical Science
- Immunotoxicology
- Biotechnology
Background:
- Recombinant DNA techniques, cell fusion, and bioprocessing have enabled the development of diverse pharmaceutical products.
- These products include direct immune modulators (e.g., interleukins, interferons) and agents with unintended immunological reactivity (e.g., peptides, NSAIDs).
Purpose of the Study:
- To highlight the importance of assessing the immunotoxicological potential of pharmaceutical products.
- To address the need for defining safety profiles during preclinical evaluation.
Main Methods:
- Discussion at a recent meeting focused on immunotoxicology assessment strategies.
- Review of product categories and their potential immune interactions.
Main Results:
- Identified a range of pharmaceutical products with direct or indirect immunological effects.
- Emphasized the necessity of evaluating immunotoxicological potential for safety.
Conclusions:
- Preclinical safety evaluation must incorporate immunotoxicology for novel pharmaceutical products.
- Understanding immune reactivity is crucial for safe drug development and deployment.
More Related Videos
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
14.4K
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
7.6K
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:31Hybridoma Technology
13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
01:23Toxicity Testing in Animals
198
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
198
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
01:25Bioactivation and Tissue Toxicity
147
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
147